Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.
There is no non-commercial support for this activity.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Target Audience
The intended audience for this educational series is hematologist-oncologists, oncologists, nurses, pharmacists, nurse practitioners, and other health care professionals involved in the treatment of patients with lung cancer.
Learning Objectives
Upon successful completion of this educational series, participants should be better able to:
- Assess the latest clinical evidence regarding the use of checkpoint inhibitors for patients with advanced lung cancer and the resulting implications for practice.
- Review the benefits of PROs and patient coaching in oncology practice and how this can be employed to improve outcomes for patients with lung cancer.
- Examine ongoing efforts within your health system to enroll patients with lung cancer in a digital patient health coaching platform to improve overall well-being.
- Examine healthcare disparities in lung cancer and strategies that might close these gaps.
Activity Chair
George R. Simon, MD, FACP, FCCP
Professor of Medicine and Section Chief
Translational Research
Department of Thoracic/Head and Neck Medical Oncology Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Faculty
Sarah Anderson, MSN, RN, AGPCNP-C, AOCNP
The University of Texas MD Anderson Cancer Center
Houston, TX
Kelly Brassil, PhD, RN
Director of Medical Affairs, Pack Health
Yasir Y. Elamin, MD
Assistant Professor
Department of Thoracic/Head and Neck Medical Oncology Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Beth Eaby-Sandy, MSN, CRNP, OCN
Jennifer Frederick, PharmD, BCPS
Barbara A. Niedz, PhD, RN, CPHQ
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education, LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education will provide a maximum of 1.0 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This program is acceptable for 1.0 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-20-005-H01-P, effective 8/17/2020. This is a knowledge-based activity, and there is no fee to attend.
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.42 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20084415. This activity was planned in accordance with AANP Accreditation Standards and Policies.
This enduring material is approved for 1 year from the date of original release, August 17, 2020, through August 16, 2021.
How to Participate in This Activity and Obtain CME Credit
To participate in this CE activity, you must read the objectives, answer the poll and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, a Contact Hours Certificate, or a CPE Statement of Credit. Vindico will report pharmacist learners to CPE monitor within 30 days of completion of the activity.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.
Activity Chair and Faculty reports the following relationship(s)
Sarah Anderson, MSN, RN, AGPCNP-C, AOCNP
No relevant financial relationships to disclose.
Kelly Brassil, PhD, RN
Contracted Research (paid to institution): AbbVie, Astellas, Daiichi, Genentech
Authorship Fees: Oncology Nursing Society
Yasir Y. Elamin, MD
No relevant financial relationships to disclose.
George R. Simon, MD, FACP, FCCP
Contracted Research (paid to institution): Merck
Reviewers report the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Beth Eaby-Sandy, MSN, CRNP, OCN
Speakers Bureau: AstraZeneca, Merck, Takeda
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
Consulting Fee: Beckton Dickinson
Contracted Research: Beckton Dickinson
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com